Search

everythinglearnresearchcommunity

for

Search:↓

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Testosterone is important for male sexual traits, reproduction, muscle and bone health, blood production, and metabolism, and works both directly and after being changed into other hormones.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.

Lipid metabolism affects wool fiber diameter in sheep.

Nanotechnology in skincare improves ingredient stability, skin penetration, and controlled release for better cosmetic solutions.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Bicalutamide may help treat female pattern hair loss.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Copper boosts cell growth in rabbit hair follicles.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Younger people may have a higher risk of hair loss due to poor nutrition and lifestyle.

Lower adiponectin and higher leptin levels may predict hair loss in alopecia areata.

Using a combined treatment of minoxidil and metformin can improve hair loss in women by normalizing hormone and metabolism levels.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Baricitinib is effective for severe alopecia areata but has some side effects.

Bald men may have higher heart disease risk.

Dietary choices, especially fat type, can influence health.

Ethosomes enhance skin penetration better than liposomes, benefiting therapeutic and cosmetic applications.